The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

Knowing your blood group is crucial for safe blood transfusions, organ transplants, and managing pregnancies to prevent Rh incompatibility.

Conditions such as thyroid nodules, hyperthyroidism, parathyroid adenomas, and adrenal tumors can be treated using minimally invasive techniques.